229 related articles for article (PubMed ID: 33727578)
41. Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma.
Qin M; Liu G; Huo X; Tao X; Sun X; Ge Z; Yang J; Fan J; Liu L; Qin W
Cancer Biomark; 2016; 16(1):161-9. PubMed ID: 26600397
[TBL] [Abstract][Full Text] [Related]
42. Circular RNA hsa_circ_0003141 promotes tumorigenesis of hepatocellular carcinoma via a miR-1827/UBAP2 axis.
Wang Y; Gao R; Li J; Tang S; Li S; Tong Q; Mao Y
Aging (Albany NY); 2020 May; 12(10):9793-9806. PubMed ID: 32464601
[TBL] [Abstract][Full Text] [Related]
43. Hsa_circ_0026134 expression promoted TRIM25- and IGF2BP3-mediated hepatocellular carcinoma cell proliferation and invasion via sponging miR-127-5p.
Zhang W; Zhu L; Yang G; Zhou B; Wang J; Qu X; Yan Z; Qian S; Liu R
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32648571
[TBL] [Abstract][Full Text] [Related]
44. Circular RNA circ-102,166 acts as a sponge of miR-182 and miR-184 to suppress hepatocellular carcinoma proliferation and invasion.
Li R; Deng Y; Liang J; Hu Z; Li X; Liu H; Wang G; Fu B; Zhang T; Zhang Q; Yang Y; Chen G; Liu W
Cell Oncol (Dordr); 2021 Apr; 44(2):279-295. PubMed ID: 33034848
[TBL] [Abstract][Full Text] [Related]
45. CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p/RTKN2 axis and activating Wnt/β-catenin pathway.
Huang G; Liang M; Liu H; Huang J; Li P; Wang C; Zhang Y; Lin Y; Jiang X
Cell Death Dis; 2020 Dec; 11(12):1065. PubMed ID: 33311442
[TBL] [Abstract][Full Text] [Related]
46. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
[TBL] [Abstract][Full Text] [Related]
47. Hsa_circ_0005986 inhibits carcinogenesis by acting as a miR-129-5p sponge and is used as a novel biomarker for hepatocellular carcinoma.
Fu L; Chen Q; Yao T; Li T; Ying S; Hu Y; Guo J
Oncotarget; 2017 Jul; 8(27):43878-43888. PubMed ID: 28410211
[TBL] [Abstract][Full Text] [Related]
48. Hsa_circ_101280 promotes hepatocellular carcinoma by regulating miR-375/JAK2.
Cao S; Wang G; Wang J; Li C; Zhang L
Immunol Cell Biol; 2019 Feb; 97(2):218-228. PubMed ID: 30302825
[TBL] [Abstract][Full Text] [Related]
49. Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients.
Shen C; Wu Z; Wang Y; Gao S; Da L; Xie L; Qie Y; Tian D; Hu H
Cancer Med; 2020 Jun; 9(11):3885-3903. PubMed ID: 32250047
[TBL] [Abstract][Full Text] [Related]
50. Piplartine attenuates the proliferation of hepatocellular carcinoma cells via regulating hsa_circ_100338 expression.
Cheng X; Tian P; Zheng W; Yan X
Cancer Med; 2020 Jun; 9(12):4265-4273. PubMed ID: 32281302
[TBL] [Abstract][Full Text] [Related]
51. CircRNA circ-0038718 promotes hepatocellular carcinoma progression through sponging miR-139-3p.
Sun R; Li H; Li J; Shen S; Cui G; Dong G
Biochem Biophys Res Commun; 2020 Dec; 533(4):845-852. PubMed ID: 33008587
[TBL] [Abstract][Full Text] [Related]
52. Overexpression of circular RNA circ_001569 indicates poor prognosis in hepatocellular carcinoma and promotes cell growth and metastasis by sponging miR-411-5p and miR-432-5p.
Liu H; Xue L; Song C; Liu F; Jiang T; Yang X
Biochem Biophys Res Commun; 2018 Sep; 503(4):2659-2665. PubMed ID: 30086881
[TBL] [Abstract][Full Text] [Related]
53. CircRNA expression profiling of PBMCs from patients with hepatocellular carcinoma by RNA-sequencing.
Han Z; Feng W; Hu R; Ge Q; Sun X; Ma W; Zhang W; Xu S; Zhan B; Zhang L; Li Q; Zhou X
Exp Ther Med; 2021 Dec; 22(6):1467. PubMed ID: 34737807
[TBL] [Abstract][Full Text] [Related]
54. Association between hsa_circ_0006156 expression and incidence of gastric cancer.
He YX; Ju H; Li N; Jiang YF; Zhao WJ; Song TT; Ren WH
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3030-3036. PubMed ID: 32271420
[TBL] [Abstract][Full Text] [Related]
55. Circular RNA expression profiles of peripheral blood mononuclear cells in hepatocellular carcinoma patients by sequence analysis.
Lei B; Zhou J; Xuan X; Tian Z; Zhang M; Gao W; Lin Y; Ni B; Pang H; Fan W
Cancer Med; 2019 Apr; 8(4):1423-1433. PubMed ID: 30714679
[TBL] [Abstract][Full Text] [Related]
56. Emerging roles of hsa_circ_0005075 targeting miR-431 in the progress of HCC.
Li MF; Li YH; He YH; Wang Q; Zhang Y; Li XF; Meng XM; Huang C; Li J
Biomed Pharmacother; 2018 Mar; 99():848-858. PubMed ID: 29710484
[TBL] [Abstract][Full Text] [Related]
57. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma.
Yu J; Xu QG; Wang ZG; Yang Y; Zhang L; Ma JZ; Sun SH; Yang F; Zhou WP
J Hepatol; 2018 Jun; 68(6):1214-1227. PubMed ID: 29378234
[TBL] [Abstract][Full Text] [Related]
58. circ-BIRC6, a circular RNA, promotes hepatocellular carcinoma progression by targeting the miR-3918/Bcl2 axis.
Yang G; Wang X; Liu B; Lu Z; Xu Z; Xiu P; Liu Z; Li J
Cell Cycle; 2019 May; 18(9):976-989. PubMed ID: 30931701
[TBL] [Abstract][Full Text] [Related]
59. Screening and bioinformatics analysis of circular RNA expression profiles in hepatitis B-related hepatocellular carcinoma.
Wang S; Cui S; Zhao W; Qian Z; Liu H; Chen Y; Lv F; Ding HG
Cancer Biomark; 2018; 22(4):631-640. PubMed ID: 29914004
[TBL] [Abstract][Full Text] [Related]
60. Hsa_circ_0013290 Acts as Cancer-Promoting Gene in Hepatocellular Carcinoma.
Luo X; Liu Y; Li H; Cheng T; Wu J; Chen L; Ju L; Cai W; Bian Z
Cancer Control; 2021; 28():10732748211055681. PubMed ID: 34798782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
